Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components

Vaccine

Volumn 23, Issue 48-49, 2005, Pages 5688-5697

  Mendelson, I ^a   Gat, O ^a   Aloni Grinstein, R ^a   Altboum, Z ^a   Inbar, I ^a   Kronman, C ^a   Bar Haim, E ^a   Cohen, S ^a   Velan, B ^a   Shafferman, A ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Bacillus anthracis; Immunoprotection; Protective antigen; Spore

Indexed keywords

ANTHRAX VACCINE; MASC 10; MASC 12; MASC 13; MASC 20; MASC 51; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIGEN; TOXIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL SPORE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; LETHAL GENE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; GUINEA PIGS; IMMUNIZATION; RECOMBINANT PROTEINS; SPORES, BACTERIAL; VACCINES, SYNTHETIC;

EID: 26944450746     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.077     Document Type: Article

References (47)

1. A.M. Friedlander Anthrax: clinical features, pathogenesis, and potential biological warfare threat Curr Clin Top Infect Dis 20 2000 335 349
2. M. Moayeri, and S.H. Leppla The roles of anthrax toxin in pathogenesis Curr Opin Microbiol 7 2004 1 6
3. M. Mock, and A. Fouet Anthrax Annu Rev Microbiol 55 2001 647 671
4. R.J. Collier, and J.A.T. Young Anthrax toxin Annu Rev Cell Dev Biol 19 2003 45 70
5. L. Baillie The development of new vaccines against Bacillus anthracis J Appl Microbiol 91 4 2001 609 613
6. P.C.B. Turnbull Current status of immunization against anthrax: old vaccines may be here to stay for a while Curr Opin Infect Dis 13 2000 113 120
7. A.V. Stepanov, L.I. Marinin, A.P. Pomerantsev, and N.A. Staritsin Development of novel vaccines against anthrax in man J Biotechnol 44 1-3 1996 155 160
8. S.F. Little, and G.B. Knudson Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig Infect Immun 52 2 1986 509 512
9. P.C. Turnbull, M.G. Broster, J.A. Carman, R.J. Manchee, and J. Melling Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity Infect Immun 52 2 1986 356 363
10. J.W. Farchaus, W.J. Ribot, S. Jendrek, and S.F. Little Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis Appl Environ Microbiol 64 3 1998 982 991
11. N.M. Coulson, M. Fulop, and R.W. Titball Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261 Microb Pathog 16 4 1994 305 311
12. L.C. Iacono-Connors, S.L. Welkos, B.E. Ivins, and J.M. Dalrymple Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals Infect Immun 59 6 1991 1961 1965
13. B.E. Ivins, and S.L. Welkos Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis Infect Immun 54 2 1986 537 542
14. B.E. Ivins, S.L. Welkos, G.B. Knudson, and S.F. Little Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen Infect Immun 58 2 1990 303 308
15. S.L. Welkos, and A.M. Friedlander Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice Microb Pathog 5 2 1988 127 139
16. O. Gat, I. Inbar, R. Aloni-Grinstein, E. Zahavy, C. Kronman, and I. Mendelson Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines Infect Immun 71 2 2003 801 813
17. L. Baillie, A. Moir, and R. Manchee The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis J Appl Microbiol 84 5 1998 741 746
18. J. Miller, B.W. McBride, R.J. Manchee, P. Moore, and L.W. Baillie Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis Lett Appl Microbiol 26 1 1998 56 60
19. B. Ivins, P. Fellows, L. Pitt, J. Estep, J. Farchaus, and A. Friedlander Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs Vaccine 13 18 1995 1779 1784
20. P.C. Turnbull Anthrax vaccines: past, present and future Vaccine 9 8 1991 533 539
21. S. Jendrek, S. Little, S. Hem, G. Mitra, and S. Giardina Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants Vaccine 21 2003 3011 3018
22. C. Pezard, P. Berche, and M. Mock Contribution of individual toxin components to virulence of Bacillus anthracis Infect Immun 59 10 1991 3472 3477
23. C. Pezard, E. Duflot, and M. Mock Construction of Bacillus anthracis mutant strains producing a single toxin component J Gen Microbiol 139 10 1993 2459 2463
24. C. Pezard, M. Weber, J.C. Sirard, P. Berche, and M. Mock Protective immunity induced by Bacillus anthracis toxin-deficient strains Infect Immun 63 4 1995 1369 1372
25. F. Brossier, M. Levy, and M. Mock Anthrax spores make an essential contribution to vaccine efficacy Infect Immun 70 2 2002 661 664
26. G.E. Rhie, M.H. Roehrl, M. Mourez, R.J. Collier, J.J. Mekalanos, and J. Wang A dually active anthrax vaccine that confers protection against both bacilli and toxins Proc Natl Acad Sci USA 100 19 2003 10925 10930
27. J.P. Barnard, and A.M. Friedlander Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen Infect Immun 67 2 1999 562 567
28. S. Cohen, I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, and T. Bino Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax Infect Immun 68 8 2000 4549 4558
29. K.R. Klimpel, S.S. Molloy, G. Thomas, and S.H. Leppla Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin Proc Natl Acad Sci USA 89 21 1992 10277 10281
30. Y. Singh, K.R. Klimpel, N. Arora, M. Sharma, and S.H. Leppla The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor J Biol Chem 269 46 1994 29039 29046
31. E.L. Benson, P.D. Huynh, A. Finkelstein, and R.J. Collier Identification of residues lining the anthrax protective antigen channel Biochemistry 37 11 1998 3941 3948
32. B.R. Sellman, M. Mourez, and R.J. Collier Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax Science 292 2001 695 697
33. J. Mogridge, M. Mourez, and R.J. Collier Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin J Bacteriol 183 6 2001 2111 2116
34. Y. Singh, K.R. Klimpel, C.P. Quinn, V.K. Chaudhary, and S.H. Leppla The carboxyl-terminal end of protective antigen is required for receptor-binding and anthrax toxin activity J Biol Chem 266 23 1991 15493 15497
35. F. Brossier, J.C. Sirard, C. Guidi-Rontani, E. Duflot, and M. Mock Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen Infect Immun 67 2 1999 964 967
36. M. Varughese, A.V. Teixeira, S. Liu, and S.H. Leppla Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin Infect Immun 67 4 1999 1860 1865
37. K.R. Klimpel, N. Arora, and S.H. Leppla Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity Mol Microbiol 13 6 1994 1093 1100
38. C.R. Harwood S.M. Cutting Molecular biological methods for Bacillus 1990 John Wiley & Sons
39. T. Maniatis, E.F. Fritsch, and J. Sambrook Molecular cloning. A laboratory manual 1982 Cold Spring Harbor Laboratory
40. B. Bron Plasmids C.R. Harwood S.M. Cutting Molecular biological methods for Bacillus 1990 John Wiley & Sons 75 174
41. T.S. Bragg, and D.L. Robertson Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis Gene 81 1 1989 45 54
42. S.F. Little, S.H. Leppla, and A.M. Friedlander Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin Infect Immun 58 6 1990 1606 1613
43. S. Reuveny, M. White, Y. Adar, Y. Kafri, Z. Altboum, and Y. Gozes Search for correlates of protective immunity conferred by anthrax vaccine Infect Immun 69 2001 2888 2893
44. J. Mogridge, K. Cunningham, D.B. Lacy, M. Mourez, and R.J. Collier The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen Proc Natl Acad Sci USA 99 10 2002 7045 7048
45. S. Liu, and S.H. Leppla Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization J Biol Chem 278 7 2003 5227 5234
46. Y. Singh, V.K. Chaudhary, and S.H. Leppla A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo J Biol Chem 264 32 1989 19103 19107
47. G. Hermanson, V. Whitlow, S. Parker, K. Tonsky, D. Rusalov, and M. Ferrari A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores Proc Natl Acad Sci USA 101 37 2004 13601 13606